About

Quantilogix is based out of beautiful Seattle in Washington State, USA. The company was founded in 2024 by Dr. Raibatak Das, PhD.

Dr. Das is an experienced and accomplished scientist with two decades of research experience spanning academia and industry. Prior to founding Quantilogix, Dr. Das was at Applied BioMath where he was involved in more than 25 industry-funded modeling projects in diverse therapeutic areas, including immuno-oncology, neuroscience, cell and gene therapies and bioconjugate therapies. He has over 20 peer-reviewed publications in high impact journals, and was the recipient of an NIH small business innovation research (SBIR) grant to model targeted cytokine therapies. Dr. Das received his Ph.D. from Cornell University.